Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Emi Sei
Research Group Leader
Systems Biology
Genetics
https://orcid.org/0000-0003-1572-3319
h-index
2919
Citations
18
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2011
2024
Research activity per year
Overview
Fingerprint
Network
Research output
(25)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Emi Sei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Genomics
100%
DNA Sequence
82%
Evolution
46%
RNA
43%
Human Herpesvirus 8
36%
RNA Sequence
30%
Cross-Link
24%
Genome Instability
24%
Immunoprecipitation
20%
Drug Resistance
18%
Tumor Progression
18%
Exome Sequencing
15%
Transcriptome
15%
T Cell
13%
Exome
13%
Copy Number Analysis
12%
LAG3
12%
Blood Plasma
12%
Chromatin Immunoprecipitation
12%
Carcinogenesis
12%
Proteomics
12%
Oligonucleotide
12%
Subcloning
12%
Loss of Heterozygosity
12%
Genome Sequencing
12%
Cooperation
12%
Aneuploidy
12%
Tumor-Infiltrating Lymphocytes
12%
Cladistics
12%
Phylogeny
12%
ATAC-Seq
12%
Metabolic Pathway
12%
Deep Sequencing
12%
Biological Phenomena and Functions Concerning the Entire Organism
12%
Open Reading Frame
12%
High Throughput Sequencing
12%
Myeloid
12%
Precursor mRNA
12%
Immune Checkpoints
12%
Karyotyping
12%
Daughter Cell
12%
Transposase
12%
Cancer Cell
11%
Tumor Suppressor Gene
9%
Gene Expression
8%
Reprogramming
8%
RNA-binding Protein
8%
Cell Adhesion
6%
Gene Loss
6%
Mass Spectrometry
6%
Keyphrases
Ductal Carcinoma in Situ
36%
Single-cell DNA Sequencing
30%
Single-cell Genomics
28%
Breast Cancer
27%
ORF57
24%
Tumor
20%
Normal Breast Tissue
18%
Invasive Breast Cancer
16%
Triple-negative Breast Cancer
14%
Breast Tumor
14%
Carboplatin
12%
Cultured Cells
12%
Primary Tumor
12%
High-throughput Sequencing
12%
Single-cell Chromatin Accessibility
12%
Evolutionary Response
12%
Tumor Immunity
12%
Durable Response
12%
T Cells
12%
Myeloid Cells
12%
Pre-mRNA
12%
Metabolism
12%
Co-immunoprecipitation (co-IP)
12%
Adult Humans
12%
Pancreatic Cancer
12%
Clonal Relationship
12%
Metastatic Tumor
12%
Metastasis
12%
Invasive Ductal Carcinoma
12%
4-1BB
12%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
12%
Cell State
12%
Crosslinking Immunoprecipitation
12%
Single-cell RNA Sequencing (scRNA-seq)
12%
Immune Checkpoint Therapy
12%
Immunological Response
12%
Kaposi's Sarcoma-associated Herpesvirus
12%
Stasis
12%
Spatially Resolved
12%
Single-nucleus RNA Sequencing
12%
Nanogrid
12%
Metastatic Colorectal Cancer (mCRC)
12%
Human Breast
12%
Copy number Evolution
12%
Subclone
12%
Genomic Analysis
12%
Cabazitaxel
12%
CXCR2
12%
CXCR1
12%
UV Crosslinking
12%
Immunology and Microbiology
DNA Sequence
62%
Lineage
42%
Human Herpesvirus 8
36%
RNA Sequence
36%
Single-Cell Sequencing
36%
Breast Tissue
33%
Transcriptomics
23%
Tumor Cell
20%
T Cell
19%
Cell Line
18%
Evolution
16%
Transcriptome
15%
Whole Exome Sequencing
14%
Gene Expression
13%
Tumor-Infiltrating Lymphocytes
12%
Open Reading Frame
12%
Immunoprecipitation
12%
Drug Resistance
12%
High Throughput Sequencing
12%
LAG3
12%
Cross Linking
12%
Immunity
12%
Myeloid
12%
Immunocompetent Cell
12%
Chromatin Immunoprecipitation
12%
Tissue Section
10%
Immunotherapy
7%
Immunosuppressive Drug
7%
Breast Cell
6%
Precursor
6%
Biological Product
6%
Cell Population
6%
Dynamics
6%
In Situ Hybridization
6%
Adipose Tissue
6%
Cancer Cell
5%
